RAB32

Across TCGA pan-cancer cohorts, RAB32 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated RAB32 data layer compared with 25 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher RAB32 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated RAB32 expression acts as an unfavorable survival marker.

PDAC, CCRCC, and GBM are the cancer types where RAB32 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Median	III,IV	0.233	0.875	<.001	45	view →
CCRCC	DFS	Tertile	III,IV	0.416	0.782	.009	18	view →
GBM	OS	Tertile	All	0.373	0.646	.008	10	view →
UCEC	DFS	Tertile	All	0.789	1.000	.004	8	view →
LUAD	DFS	Median	II,III,IV	0.178	0.731	.005	5	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RAB32–PDAC (OS)

Open the PDAC breakdown →